DarioHealth

DRIO

Market cap $81.8M

The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in DarioHealth (DRIO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform Innovative new pricing model is highly attractive to prospective clients – supports Dario's continued market momentum and leading position as value-based solution provider NEW YORK , Oct. 13, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the addition of six (6) new employer clients to its growing portfolio, underscoring accelerating demand for integrated, multi-condition digital health solutions that improve health and reduce costs, as well as the deployment of a new pricing model that deepens the Company's value-based care strategy. This value-based pricing framework ties payments directly to member engagement and clinical progress – a structure that aims to help clients navigate costs by leveraging Dario's industry leading platform that delivers 5X return on investment ("ROI") and approximately $5,000 annual saving per Dario user.

Collaboration designed to drive measurable return on investment ("ROI") for health plans by reducing falls and improving outcomes for high-risk populations, including those with obesity and Medicare Advantage members with frailty and balance issues Generating more than $50 billion annually in direct medical costs, falls are one of the leading causes of injury among older adults in the U.S. NEW YORK , Oct. 6, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, and OneStep, the U.S. Food and Drug Administration ("FDA")-listed platform that delivers clinical-grade gait and mobility insights using only a smartphone, today announced a strategic collaboration to integrate OneStep's clinical-grade fall risk assessment and prevention capabilities within DarioHealth's digital health solutions ecosystem. The parties have signed a Memorandum of Understanding ("MOU") and expect to conclude a Master Services Agreement in the coming weeks.

Board forms Special Committee and engages Perella Weinberg Partners as financial advisor Company completed an oversubscribed $17.5 million private placement to capitalize on significant commercial momentum Dario optimized its cap table by converting preferred shares into common shares and common shares equivalents, positioning it for future opportunities NEW YORK , Sept. 25, 2025 /PRNewswire/ --  DarioHealth Corp.  (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in digital health solutions for chronic condition management, today announced that its Board of Directors has initiated a comprehensive strategic review to maximize shareholder value following multiple unsolicited inbound strategic inquiries from interested parties.

NEW YORK , Sept. 22, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a private placement for the purchase and sale of 2,713,180 shares of common stock (or common stock equivalents in lieu thereof) at a price of $6.45 per share for expected aggregate gross proceeds of approximately $17.5 million, before deducting offering expenses.

NEW YORK , Sept. 3, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today issued a shareholder update highlighting strategic progress, robust market tailwinds, and accelerating growth opportunities.

New customer launches representing 107,000 lives covered reinforce Dario's B2B2C momentum and recurring revenue growth Dario's multi-condition digital health solutions deliver real-time results for prediabetes, diabetes, and hypertension resulting in a 23% reduction in hospitalizations, 9% reduction in healthcare utilization, and $5,000 reduction in employer costs per user 80% of the new accounts signed in 2025 are for multi-condition programs Pipeline of commercial opportunities increases to $67 million NEW YORK , Sept. 2, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the launch of five new contracts with self-insured employers.

NEW YORK , Aug. 25, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share (the "Common Stock") at a ratio of 20-for-1 is expected to be implemented at market open on August 28, 2025. The Company's Common Stock will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on August 28, 2025, under the Company's existing trading symbol "DRIO", but will trade under a new CUSIP Number, 23725P 308.

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.06 per share a year ago.

DarioHealth Corp. (NASDAQ:DRIO ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Chen Franco-Yehuda - CFO, Treasurer & Secretary Erez Raphael - CEO & Director Steven C. Nelson - President & Chief Commercial Officer Zoe Harrison - Corporate Participant Conference Call Participants Theodore Rudd O'Neill - Litchfield Hills Research, LLC Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Second Quarter 2025 Results Conference Call.